Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDORE: Neoadjuvant Pembrolizumab in MIBC
NCT03212651Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in muscle-invasive bladder cancer (MIBC), sponsored by Gustave Roussy. Started Oct 2017; status: completed.
02
Drugs
03
Conditions
muscle-invasive bladder cancer (MIBC)
Beyond the preview
Go deeper on NCT03212651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212651.